Sök artiklar i SveMed+

Observera: SveMed+ upphör att uppdateras!



Systemic inflammation in COPD is not influenced by pulmonary rehabilitation
Engelsk titel: Systemic inflammation in COPD is not influenced by pulmonary rehabilitation Läs online Författare: Sciriha, Anabel ; Lungaro-Mifsud, Stephen ; Bonello, AnneMarie ; Agius, Tonio ; Scerri, Josianne ; Ellul, Bridget ; Camilleri, Liberato ; Montefort, Stephen ; Fenech, Anthony Språk: Eng Antal referenser: 41 Dokumenttyp: Artikel UI-nummer: 18020032

Tidskrift

European Journal of Physiotherapy 2017;19(4)194-200 ISSN 2167-9169 E-ISSN 2167-9177 KIBs bestånd av denna tidskrift Denna tidskrift är expertgranskad (Peer-Reviewed)

Sammanfattning

Purpose: Pulmonary rehabilitation is known to lead to improvements in exercise tolerance, healthrelated quality of life and help reduce symptoms. Exercise, one of the largest components of such an intervention, although of great benefit, can increase the inflammatory response related to chronic obstructive pulmonary disease, depending on intensity and duration. Through this study, the effects of a 12week, high-intensity PR programme on COPD inflammatory-related markers were investigated. Materials and methods: This study is a longitudinal, observational type of study. Sixty COPD patients were enrolled, 49 of which completed the programme. A 2-h high-intensity PR programme was delivered, twice weekly for 12 weeks. The following markers were assessed at baseline, 4, 8 and 12 weeks through rehabilitation – C-reactive protein, erythrocyte sedimentation rate, neutrophil, eosinophil counts, complete blood count, six-minute walk test and St. George’s Respiratory Questionnaire. Serum amyloid A levels were assessed at baseline, week 8 and 12 and exhaled NO at baseline and upon completion of the programme. Results: This 12-week PR programme resulted in no changes in the inflammatory markers but resulted in significant improvements in both the 6MW distance and health quality of life. Conclusions: Beneficial effects on functional and HRQoL measures resulted, which, however, appear unrelated to changes in the systemic inflammatory markers.